Hung Rachel K Y, Binns-Roemer Elizabeth, Booth John W, Hilton Rachel, Harber Mark, Santana-Suarez Beatriz, Campbell Lucy, Fox Julie, Ustianowski Andrew, Cosgrove Catherine, Burns James E, Clarke Amanda, Price David A, Chadwick David, Onyango Denis, Hamzah Lisa, Bramham Kate, Sabin Caroline A, Winkler Cheryl A, Post Frank A
King's College London, London, UK.
Basic Research Laboratory, Frederick National Laboratory for Cancer Research and the National Cancer Institute, Frederick, Maryland, USA.
Kidney Int Rep. 2022 Jan 25;7(4):786-796. doi: 10.1016/j.ekir.2022.01.1054. eCollection 2022 Apr.
Variants of the gene are associated with chronic kidney disease (CKD) in people of African ancestry, although evidence for their impact in people with HIV are sparse.
We conducted a cross-sectional study investigating the association between renal risk alleles and kidney disease in people of African ancestry with HIV in the UK. The primary outcome was end-stage kidney disease (ESKD; estimated glomerular filtration rate [eGFR] of <15 ml/min per 1.73 m, chronic dialysis, or having received a kidney transplant). The secondary outcomes included renal impairment (eGFR <60 ml/min per 1.73 m), albuminuria (albumin-to-creatinine ratio [ACR] >30 mg/mmol), and biopsy-proven HIV-associated nephropathy (HIVAN). Multivariable logistic regression was used to estimate the associations between high-risk genotypes (G1/G1, G1/G2, G2/G2) and kidney disease outcomes.
A total of 2864 participants (mean age 48.1 [SD 10.3], 57.3% female) were genotyped, of whom, 354 (12.4%) had high-risk genotypes, and 99 (3.5%) had ESKD. After adjusting for demographic, HIV, and renal risk factors, individuals with high-risk genotypes were at increased odds of ESKD (odds ratio [OR] 10.58, 95% CI 6.22-17.99), renal impairment (OR 5.50, 95% CI 3.81-7.95), albuminuria (OR 3.34, 95% CI 2.00-5.56), and HIVAN (OR 30.16, 95% CI 12.48-72.88). An estimated 49% of ESKD was attributable to high-risk genotypes.
high-risk genotypes were strongly associated with kidney disease in people of African ancestry with HIV and accounted for approximately half of ESKD cases in this cohort.
该基因的变异与非洲裔人群的慢性肾脏病(CKD)相关,不过其对HIV感染者影响的证据较为稀少。
我们开展了一项横断面研究,调查英国非洲裔HIV感染者中该肾风险等位基因与肾脏疾病之间的关联。主要结局为终末期肾病(ESKD;估计肾小球滤过率[eGFR]<15 ml/min/1.73 m²、慢性透析或接受过肾移植)。次要结局包括肾功能损害(eGFR<60 ml/min/1.73 m²)、蛋白尿(白蛋白与肌酐比值[ACR]>30 mg/mmol)以及经活检证实的HIV相关性肾病(HIVAN)。采用多变量逻辑回归来估计高风险基因型(G1/G1、G1/G2、G2/G2)与肾脏疾病结局之间的关联。
总共对2864名参与者(平均年龄48.1岁[标准差10.3],57.3%为女性)进行了基因分型,其中354人(12.4%)具有高风险基因型,99人(3.5%)患有ESKD。在对人口统计学、HIV和肾脏风险因素进行调整后,具有高风险基因型的个体发生ESKD的几率增加(比值比[OR]10.58,95%置信区间6.22 - 17.99)、肾功能损害(OR 5.50,95%置信区间3.81 - 7.95)、蛋白尿(OR 3.34,95%置信区间2.00 - 5.56)以及HIVAN(OR 30.16,95%置信区间12.48 - 72.88)。估计49%的ESKD可归因于高风险基因型。
高风险基因型与非洲裔HIV感染者的肾脏疾病密切相关,在该队列中约占ESKD病例的一半。